Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary results.

Theresia Sarabhai, Alexander Tschischka, Vanessa Stebner, Felix Nensa, Axel Wetter, Rainer Kimmig, Michael Forsting, Ken Herrmann, Lale Umutlu, Johannes Grueneisen
March 2018
PDF Cite DOI

Abstract

To assess the response to initial treatment strategies of cervical cancer using multiparametric-PET/MRI. PET/MR-derived morphological (tumor size), functional (DWI, DCE-MRI) and metabolic (18F-FDG PET) parameters were acquired in pre- and posttreatment examinations of 8 patients. Besides RECIST- and PERCIST-criteria, functional quantitative parameters were used to assess therapeutic response. RECIST- and PERCIST-response criteria demonstrated high correlations for the differentiation between therapy-responders and non-responders, which was additionally reflected by functional (DWI, DCE-MRI) quantitative imaging parameters. Multiparametric-PET/MRI bears the potential of a more comprehensive response assessment of initial treatment strategies in cervical cancer patients.

Click the Cite button above to demo the feature to enablevisitors to import publication metadata into their reference management software.
Felix Nensa
Felix Nensa
Lead

My research interests include medical digitalization, computer vision and radiology.